Nitric oxide inhibits arginine-vasotocin-induced increase of water osmotic permeability in frog urinary bladder

Pflugers Archiv European Journal of Physiology

Volumn 448, Issue 2, 2004, Pages 197-203

  Fock, Ekaterina M ^a   Lavrova, Elena A ^a   Bachteeva, Vera T ^a   Chernigovskaya, Elena V ^a   Parnova, Rimma G ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Arginine vasotocin; cGMP; Frog urinary bladder; Nitric oxide; NO synthase; Osmotic water permeability

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; 9 (2 HYDROXY 3 NONYL)ADENINE; ARGIPRESTOCIN; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANOSINE DERIVATIVE; GUANYLATE CYCLASE INHIBITOR; KT 5823; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; PHOSPHORUS DERIVATIVE; RINGER SOLUTION; SPLEEN EXONUCLEASE; UNCLASSIFIED DRUG; WATER; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; CONTROLLED STUDY; FROG; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR WEIGHT; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; WATER FLOW; WATER PERMEABILITY; WATER TRANSPORT;

ADENINE; ANIMALS; CARBAZOLES; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; EXONUCLEASES; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; INDOLES; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITROPRUSSIDE; OSMOTIC PRESSURE; PERMEABILITY; PHOSPHODIESTERASE INHIBITORS; RANA TEMPORARIA; URINARY BLADDER; VASOTOCIN;

EID: 2442521206     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00424-003-1233-6     Document Type: Article

References (24)

1. Beavo JA (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 75:725-748
2. Bentley PJ (1958) The effects of neurohypophyseal extracts on water transfer across the wall of the isolated urinary bladder of the toad Bufo marinus. J Endocrinol 17:201-209
3. Bouley R, Breton S, Sun T-X, McLaughlin M, Nsumu NN, Lin HY, Ausiello DA, Brown D (2000) Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest 106:1115-1126
4. Bradford MM (1976) A rapid and sensitive method for the quantitation microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254
5. Butt E, Nolte C, Schulz S, Bellman J, Beavo JA, Jastorff B, Walter U (1992) Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem Pharmacol 12:2591-2600
6. Chiu T, Reid IA (1996) Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion. J Pharmacol Exp Ther 278:793-799
7. Garcia NH, Pomposiello SI, Garvin JL (1996) Nitric oxide inhibits ADH-stimulated osmotic water permeability in cortical collecting ducts. Am J Physiol 270:F206-F210
8. Garcia NH, Stoos BA, Carretero OA, Garvin JL (1996) Mechanism of the nitric oxide-induced blockade of collecting duct water permeability. Hypertension 27:679-683
9. He H, Podymow T, Zimpelmann J, Burns KD (2003) NO inhibits Na-K-2Cl-cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1). Am J Physiol 284:F1235-F1244
10. Hidaka H, Kobayashi R (1992) Pharmacology of protein kinase inhibitors. Annu Rev Pharmacol Toxicol 32:377-397
11. Hirsch JR, Cermak R, Forssmann W-G, Kleta R, Kruhoffer M, Kuhn M, Schafer JA, Sun D, Schlatter E (1997) Effects of sodium nitroprusside in the rat cortical collecting duct are independent of the NO pathway. Kidney Int 51:473-476
12. Kerschbaum HH, Huang S, Mingqiang X, Hermann A (2000) NADPH-diaphorase activity and nitric oxide synthase activity in the kidney of the clawed frog, Xenopus laevis. Cell Tissue Res 301:405-411
13. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 261: F1033-F1037
14. Lee EYW, Humphreys MH (1996) Phosphodiesterase activity as a mediator of renal resistance to ANP in pathological salt retention. Am J Physiol 271:F3-F6
15. Majid DS, Williams A, Kadowitz PJ, Navar LG (1993) Renal responses to intra-arterial administration of nitric oxide donor in dogs. Hypertension 22:535-541
16. Mehats C, Andersen CB, Filopanti M, Jin S-LC, Conti M (2002) Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab 13:29-35
17. 2+ signaling in inner medullary collecting duct. Hypertension 39:465-469
18. Omachi RS, Robbie DE, Handler JS, Orloff J (1974) Effects of ADH and other agents on cyclic AMP accumulation in toad bladder epithelium. Am J Physiol 226:1152-1157
19. Orloff J, Handler JS (1962) The similarity of effects of vasopressin, adenosine-3,5-monophosphate (cyclic AMP) and theophylline in the toad bladder. J Clin Invest 41:702-709
20. Ortiz PA, Garvin JL (2001) NO inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase. Hypertension 37:467-471
21. Piccini Z, Parisi M (1973) Effect of guanosine-3′-5′- monophosphate on the hydroosmotic activity of adenosine-3′-5′- monophosphate in toad urinary bladder. Biochim Biophys Acta 311:625-629
22. Schnackenberg C, Patel AR, Kirchner KA, Granger JP (1997) Nitric oxide, the kidney and hypertension. Clin Exp Pharmacol Physiol 24:600-606
23. Star RA, Nonoguchi H, Balaban R, Knepper MA (1988) Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct. J Clin Invest 81:1879-1888
24. Wang X, Lu M, Gao Y, Papapetropoulos A, Sessa WC, Wang W (1998) Neuronal nitric oxide synthase is expressed in principal cell of the collecting duct. Am J Physiol 275:F395-F399